- Home
- ALLT vs BNTC Comparison
ALLT vs BNTC Comparison
Compare ALLT & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLT
- BNTC
- Stock Information
- Founded
- ALLT 1996
- BNTC 1995
- Country
- ALLT Israel
- BNTC United States
- Employees
- ALLT N/A
- BNTC N/A
- Industry
- ALLT Telecommunications Equipment
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- ALLT Telecommunications
- BNTC Health Care
- Exchange
- ALLT Nasdaq
- BNTC Nasdaq
- Market Cap
- ALLT 342.5M
- BNTC 335.5M
- IPO Year
- ALLT 2006
- BNTC N/A
- Fundamental
- Price
- ALLT $7.86
- BNTC $13.24
- Analyst Decision
- ALLT Buy
- BNTC Strong Buy
- Analyst Count
- ALLT 1
- BNTC 5
- Target Price
- ALLT N/A
- BNTC $26.00
- AVG Volume (30 Days)
- ALLT 535.2K
- BNTC 40.8K
- Earning Date
- ALLT 08-14-2025
- BNTC 09-25-2025
- Dividend Yield
- ALLT N/A
- BNTC N/A
- EPS Growth
- ALLT N/A
- BNTC N/A
- EPS
- ALLT N/A
- BNTC N/A
- Revenue
- ALLT $95,342,000.00
- BNTC N/A
- Revenue This Year
- ALLT $10.64
- BNTC N/A
- Revenue Next Year
- ALLT $15.76
- BNTC N/A
- P/E Ratio
- ALLT N/A
- BNTC N/A
- Revenue Growth
- ALLT 4.74
- BNTC N/A
- 52 Week Low
- ALLT $2.75
- BNTC $8.06
- 52 Week High
- ALLT $10.77
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- ALLT 51.18
- BNTC 59.72
- Support Level
- ALLT $7.71
- BNTC $12.57
- Resistance Level
- ALLT $8.10
- BNTC $13.33
- Average True Range (ATR)
- ALLT 0.44
- BNTC 0.60
- MACD
- ALLT 0.09
- BNTC 0.10
- Stochastic Oscillator
- ALLT 59.12
- BNTC 95.59
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.